Capstone Investment Advisors
TFFP

Capstone Investment Advisors’s TFF Pharmaceuticals, Inc. Common Stock TFFP Stock Holding History

Capstone Investment Advisors’s Portfolio TFFP Stock Details TFFP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-589
Closed -$211K – 1977
2020
Q4 		$211K Buy
+589
New +$227K ﹤0.01% 1446

Other funds holding TFFP

CA
Corriente Advisors Fort Worth, Texas $9.53M AUM 805.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DS
DRW Securities Chicago, Illinois $7.21B AUM 20.54% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
GS
Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACM
Altium Capital Management New York $42M AUM
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
GPCM
Granite Point Capital Management Boston, Massachusetts $4.9M AUM 38.41% 1-Year Est. Return

Capstone Investment Advisors's TFFP Position: Q1 2021 in Review

Capstone Investment Advisors sold out of TFF Pharmaceuticals, Inc. Common Stock (TFFP) in Q1 2021, closing a stake of 589 shares — an estimated $211K sold.

Capstone Investment Advisors first reported a position in TFFP in Q4 2020 and held it in 1 quarter. The position peaked at $211K in Q4 2020. 63 funds tracked by Wall St. Rank hold TFFP as of Q1 2021.

  • Capstone Investment Advisors reported no remaining TFF Pharmaceuticals, Inc. Common Stock position as of Q1 2021 after selling out during the quarter.
  • Capstone Investment Advisors sold 589 TFF Pharmaceuticals, Inc. Common Stock shares in Q1 2021, an estimated $211K.
  • Capstone Investment Advisors first reported a position in TFF Pharmaceuticals, Inc. Common Stock in Q4 2020 and held it in 1 quarter.
  • Capstone Investment Advisors's TFF Pharmaceuticals, Inc. Common Stock position peaked at $211K in Q4 2020.
  • 63 funds tracked by Wall St. Rank held TFF Pharmaceuticals, Inc. Common Stock as of Q1 2021.

Based on Capstone Investment Advisors's 13F filing for Q1 2021, filed 17 May 2021.